Vycor Medical (VYCO) Return on Capital Employed (2011 - 2026)
Vycor Medical (VYCO) reported Return on Capital Employed of 2.25% for Q1 2026, down 259.0% year-over-year from 1.42% in Q1 2025, and down 158.94% on a QoQ basis from 0.87% in Q4 2025.
Vycor Medical (VYCO) has 16 years of Return on Capital Employed data on file, last reported at 2.25% in Q1 2026.
- Quarterly Return on Capital Employed fell 259.0% year-over-year to 2.25% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2.25% (down 259.0% YoY) and the FY2025 annual result came in at 0.88%, down 114.0% from the prior year.
- Return on Capital Employed declined to 2.25% in Q1 2026 per VYCO's latest filing, from 0.87% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 15.61% in Q2 2022 and bottomed at 2.3% in Q3 2025.
- The 5-year median for Return on Capital Employed is 0.34% (2025), against an average of 3.51%.
- The widest annual swing landed in 2022, when Return on Capital Employed surged 1935 bps; it then sank 1452 bps in 2023.
- Tracing VYCO's Return on Capital Employed over 5 years: stood at 11.15% in 2022, then plunged by 112 bps to 1.32% in 2023, then jumped by 120 bps to 0.26% in 2024, then tumbled by 429 bps to 0.87% in 2025, then slumped by 159 bps to 2.25% in 2026.
- Per Business Quant, the three latest VYCO Return on Capital Employed figures stand at 2.25% (Q1 2026), 0.87% (Q4 2025), and 2.3% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 7.62% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 11.57% |
| 10 | Vycor Medical | - | - | 375,153.00 | -2.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.25% |
| Dec 31, 2025 | -0.87% |
| Sep 30, 2025 | -1.96% |
| Jun 30, 2025 | -0.25% |
| Mar 31, 2025 | 0.70% |
| Dec 31, 2024 | 0.65% |
| Sep 30, 2024 | 2.63% |
| Jun 30, 2024 | 2.49% |
| Mar 31, 2024 | 0.08% |
| Dec 31, 2023 | -1.32% |
| Sep 30, 2023 | -0.43% |
| Jun 30, 2023 | 1.70% |
| Mar 31, 2023 | 7.50% |
| Dec 31, 2022 | 11.15% |
| Sep 30, 2022 | 14.10% |
| Jun 30, 2022 | 15.61% |
| Mar 31, 2022 | 11.66% |
| Dec 31, 2021 | 20.16% |
| Sep 30, 2021 | 21.74% |
| Jun 30, 2021 | 27.92% |
| Mar 31, 2021 | 38.63% |
| Dec 31, 2020 | 41.97% |
| Sep 30, 2020 | 39.82% |
| Jun 30, 2020 | 45.45% |
| Mar 31, 2020 | 42.14% |
| Dec 31, 2019 | 46.75% |
| Sep 30, 2019 | 74.18% |
| Jun 30, 2019 | 89.99% |
| Mar 31, 2019 | 112.97% |
| Dec 31, 2018 | 224.94% |
| Sep 30, 2018 | 248.28% |
| Jun 30, 2018 | 707.79% |
| Mar 31, 2018 | 541.06% |
| Dec 31, 2017 | -578.82% |
| Sep 30, 2017 | -312.90% |
| Jun 30, 2017 | -146.44% |
| Mar 31, 2017 | -303.64% |
| Dec 31, 2016 | -71,346.42% |
| Sep 30, 2016 | -327.72% |
| Jun 30, 2016 | -247.74% |
| Mar 31, 2016 | -172.57% |
| Mar 31, 2015 | -87.85% |
| Jun 30, 2014 | -71.41% |
| Mar 31, 2014 | -343.70% |
| Dec 31, 2013 | 70.38% |
| Sep 30, 2013 | 77.86% |
| Jun 30, 2013 | 106.59% |
| Mar 31, 2013 | 134.56% |
| Dec 31, 2012 | 200.75% |
| Sep 30, 2012 | 265.00% |
| Jun 30, 2012 | 3,355.96% |
| Mar 31, 2012 | -967.84% |
| Dec 31, 2011 | -358.61% |
| Sep 30, 2011 | -243.73% |